| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.06 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.095 | 0.08 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.09 | 0.08 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.092 | 0.08 |